Public hospital nurse here (restructured hospital under MOH). Adding the public healthcare perspective:
If you're a Singapore citizen or PR and qualify for T2D treatment, GLP-1s at public hospitals (SGH, NUH, TTSH, CGH) are subsidised:
- Ozempic at subsidised rate: SGD$180-250/month depending on your subsidy tier (based on means testing)
- Pioneer/Merdeka Generation patients get additional subsidies — can be as low as SGD$80-120/month
- CDMP + Medisave combination can bring effective cost down further
The catch: public hospital endocrinology wait times are 3-6 months for a new appointment. And they're very strict about the T2D indication — they won't prescribe for weight management alone.
For Singaporean citizens with T2D, the public healthcare route is genuinely affordable. For obesity-only patients or expats without T2D, private clinics are the only realistic option.
Excellent thread. Key takeaways for anyone in Singapore:
- Legal options: Ozempic, Mounjaro, Saxenda, Rybelsus — all available through licensed doctors. Off-label obesity prescribing is legal but cash-pay only.
- Illegal: Research peptides, compounded GLP-1s, undeclared imports. Don't risk it — Singapore's penalties are severe and enforcement is real.
- Cost reduction: Public hospital subsidies (citizens/PR with T2D), JB cross-border purchasing, or international health insurance.
- Budget option: JB day trip — Ozempic at ~SGD$200-255/month vs SGD$420-550 in SG.
- Coming soon: Wegovy HSA registration is expected in 2026, which may open more coverage pathways.
Singapore is one of the safest places in the world to use GLP-1s — because the regulatory framework ensures everything available is legitimate. The downside is zero flexibility and high prices. Trade-offs.